BURWIG SUSAN E 4

What Happened

• Susan E. Burwig, Executive Vice President, Operations at Medpace Holdings, exercised stock options on March 18, 2026. She acquired 12,000 shares at an exercise price of $166.73 per share, for a total cash outlay of $2,000,760. The filing also shows a related derivative disposition of 12,000 units at $0, which reflects the conversion/disposition of the option instrument upon exercise (transaction code M).

Key Details

• Transaction date: 2026-03-18
• Exercise details: 12,000 shares acquired @ $166.73 each = $2,000,760 (code M: option exercise)
• Related derivative entry: 12,000 units disposed @ $0 (reflects conversion of the option to shares)
• Shares owned after transaction: not disclosed in this filing
• Footnote: the option vested in full on October 27, 2025
• Filing date: 2026-03-19 — filing appears timely (not marked late)

Context

• This was an option exercise (insider used vested options to acquire shares), not an open-market sale. The cash exercise indicates Burwig paid the exercise price rather than a documented cashless sale in this filing. Option exercises are routine for executives when options vest; they are informative about compensation realization but do not by themselves indicate a buy/sell market view.